August J. Moretti
2016 - DepoMed
In 2016, August J. Moretti earned a total compensation of $1.8M as Chief Financial Officer and Senior Vice President at DepoMed, a 21% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $183,042 |
---|---|
Option Awards | $591,491 |
Salary | $418,820 |
Stock Awards | $602,625 |
Other | $9,481 |
Total | $1,805,459 |
Moretti received $602.6K in stock awards, accounting for 33% of the total pay in 2016.
Moretti also received $183K in non-equity incentive plan, $591.5K in option awards, $418.8K in salary and $9.5K in other compensation.
Rankings
In 2016, August J. Moretti's compensation ranked 5,366th out of 14,075 executives tracked by ExecPay. In other words, Moretti earned more than 61.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,366 out of 14,075 | 62nd |
Division Manufacturing | 1,924 out of 5,489 | 65th |
Major group Chemicals And Allied Products | 611 out of 1,895 | 68th |
Industry group Drugs | 456 out of 1,538 | 70th |
Industry Pharmaceutical Preparations | 364 out of 1,176 | 69th |
Source: SEC filing on July 14, 2017.
Moretti's colleagues
We found five more compensation records of executives who worked with August J. Moretti at DepoMed in 2016.
2016
James Schoeneck
DepoMed
Chief Executive Officer
2016
R Shively
DepoMed
Former Senior Vice President and Chief Commercial Officer
2016
Matthew Gosling
DepoMed
General Counsel
2016
Srinivas Rao
DepoMed
Chief Medical Officer
2016
Thadd Vargas
DepoMed